Ep. 88 - Jason Williams on How Alastin Doubled Down on the Science of Skincare

11/07/23 • 28 min

"Alastin is certainly not the only brand in our offices, but it is my number one brand. And it's based on the science." — Dr. Grant Stevens

For far too long, skincare was more about style than substance. Flashy marketing and misleading claims wrapped around largely generic ingredients became the rinse and repeat formula for cosmetic brands.

While we've seen no shortage of technical progress in the world of aesthetic medicine, the skincare category has suffered from a dearth of true scientific innovation.

The above context is necessary to provide a backdrop against which to project just how refreshing it is to speak with Jason Williams, the Vice President of Sales at Alastin Skincare.

In this episode, he provides valuable insights into how Alastin's dedication to science forms the bedrock of its skincare research and innovation.

Tune in to hear about a brand-new topical vitamin C serum proven not to disrupt elastin and collagen, and learn Jason's best tips for physician-led product pullthrough on the latest episode of The Technology of Beauty.

» Apple Podcasts | https://podcasts.apple.com/us/podcast/technology-of-beauty/id1510898426
» Spotify | https://open.spotify.com/show/0hEIiwccpZUUHuMhlyCOAm
» Recent episodes | https://www.influxmarketing.com/technology-of-beauty/
» Instagram | https://www.instagram.com/thetechnologyofbeauty/
» LinkedIn | https://www.linkedin.com/company/the-technology-of-beauty/
The Technology of Beauty is produced by Influx Marketing, The Digital Agency for Aesthetic Practices. https://www.influxmarketing.com/
Want more aesthetic insights? Subscribe to Next Level Practices, the show where we discuss the ever-changing world of digital marketing and patient acquisition and bring you the latest ideas, strategies, and tactics to help you take your practice to the next level. https://www.influxmarketing.com/next-level-practices/

"Alastin is certainly not the only brand in our offices, but it is my number one brand. And it's based on the science." — Dr. Grant Stevens

While we've seen no shortage of technical progress in the world of aesthetic medicine, the skincare category has suffered from a dearth of true scientific innovation.

The above context is necessary to provide a backdrop against which to project just how refreshing it is to speak with Jason Williams, the Vice President of Sales at Alastin Skincare.

In this episode, he provides valuable insights into how Alastin's dedication to science forms the bedrock of its skincare research and innovation.

Previous Episode

Ep. 87 - Tyler Terry on Rethinking the Patient Consult Process

Imagine distilling the entire essence of an aesthetic practice into an iPad.
To state it simply, that's just what the TouchMD platform makes possible — but there's a whole lot more to unpack. You could call it a patient engagement platform, a Before and After photo solution, or a patient consultation tool, and you would be right on all counts. But the true power lies in bringing all these components together and making them available at every touch point so that the patient gets served just the right content at just the right time and with the right end goal in mind.
Perhaps mostly powerfully, TouchMD seeks to harness that distilled essence of a practice in order to maximize patient-provider time in a way that equates to higher conversion rates, increased cross-selling and up-selling, and higher all-around patient satisfaction.
So how does TouchMD help aesthetic practices around the country do all this? Tune in to hear it straight from TouchMD's President of Sales & Marketing, Tyler Terry.
Having been with the company for over 11 years, Tyler isn't shy in claiming that it is the #1 software in the aesthetic industry. More importantly, his genuine passion comes through when he talks about what the platform can do to create better-educated, empowered patients, for the benefit of all concerned.
Find out how TouchMD is rethinking the patient consult process, and stick around for when Tyler reveals what the future holds for TouchMD, all on the latest episode of The Technology of Beauty.

Next Episode

Ep. 89 - Jason Richey on Launching a New Category for Non-Surgical Skin Rejuvenation

How often does a genuinely novel aesthetic device make it past product-launch hurdles to make it into practices across the country?
Enter Jason Richey, President & CEO of Cytrellis Biosystems, to tell us about the nascent success of the Ellacor Micro-Coring system — the first of its kind to receive FDA clearance.
The brainchild of Cytrellis Founders Dr. Rox Anderson and Dr. Jay Austen, the Ellacor device uses hollow needles to remove "micro-cores" of skin less than .5 millimeters in diameter, causing the body's natural healing response to go into effect. Up to 8% of the skin in the treatment area can be removed, with the goal of improving skin architecture by allowing the skin to realign to close the cores.
Currently cleared for facial procedures, the device purports to fill a need for patients for patients interested in tightening and rejuvenating skin without a facelift.
With 120 devices installed as of the taping of this episode, and a goal of 300 installs by year-end, the future is looking bright for Ellacor. Tune in to find out what the potential of a wide range of additional applications could mean for complimentary dermal rejuvenation procedures on the latest episode of The Technology of Beauty.